CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy

Journal of Clinical Virology

Volumn 53, Issue 1, 2012, Pages 29-32

  Boulassel, Mohamed Rachid ^a,b   Chomont, Nicolas ^c   Pai, Nitika Pant ^d   Gilmore, Norbert ^b   Sékaly, Rafick Pierre ^c,e   Routy, Jean Pierre ^a,b  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c VGTI Florida   (United States)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Antiretroviral therapy; HIV 1; Nadir CD4 T cells; Reservoir

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE CARRIER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIMIT OF DETECTION; MALE; MEDICAL RECORD REVIEW; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DISEASE RESERVOIRS; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; VIRAL LOAD; VIREMIA; VIRUS INTEGRATION;

EID: 83355173944     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.09.018     Document Type: Article

References (28)

1. Chun T.W., Justement J.S., Murray D., Hallahan C.W., Maenza J., Collier A.C., et al. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication. AIDS 2010, 24:2803-2808.
2. Finzi D., Hermankova M., Pierson T., Carruth L.M., Buck C., Chaisson R.E., et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
3. Wong J.K., Hezareh M., Günthard H.F., Havlir D.V., Ignacio C.C., Spina C.A., et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997, 278:1291-1295.
4. Chun T.W., Stuyver L., Mizell S.B., Ehler L.A., Mican J.A., Baseler M., et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A 1997, 94:13193-13197.
5. Chomont N., El-Far M., Ancuta P., Trautmann L., Procopio F.A., Yassine-Diab B., et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009, 15:893-900.
6. Dinoso J.B., Kim S.Y., Wiegand A.M., Palmer S.E., Gange S.J., Cranmer L., et al. Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci U S A 2009, 106:9403-9408.
7. Buzón M.J., Massanella M., Llibre J.M., Esteve A., Dahl V., Puertas M.C., et al. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat Med 2010, 16:460-465.
8. Yukl S.A., Shergill A.K., McQuaid K., Gianella S., Lampiris H., Hare C.B., et al. Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. AIDS 2010, 24:2451-2460.
9. Yilmaz A., Verhofstede C., D'avolio A., Watson V., Hagberg L., Fuchs D., et al. Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy. J Acquir Immune Defic Syndr 2010, 55:590-596.
10. Chun T.W., Justement J.S., Moir S., Hallahan C.W., Maenza J., Mullins J.I., et al. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus. J Infect Dis 2007, 195:1762-1764.
11. Hocqueloux L., Prazuck T., Avettand-Fenoel V., Lafeuillade A., Cardon B., Viard J.P., et al. Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection. AIDS 2010, 24:1598-1601.
12. Strain M.C., Little S.J., Daar E.S., Havlir D.V., Gunthard H.F., Lam R.Y., et al. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis 2005, 191:1410-1418.
13. Schmid A., Gianella S., von Wyl V., Metzner K.J., Scherrer A.U., Niederöst B., et al. Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection. PLoS One 2010, 5:e13310.
14. Routy J.P., Vanhems P., Rouleau D., Tsoukas C., Lefèbvre E., Côté P., et al. Comparison of clinical features of acute HIV-1 infection in patients infected sexually or through injection drug use. The Investigators of the Québec Primary HIV Infection Study. J Acquir Immune Defic Syndr 2000, 24:425-432.
15. Boulassel M.R., Mercier F., Gilmore N., Routy J.P. Immunophenotypic patterns of CD8+ T cell subsets expressing CD8alpha and IL-7Ralpha in viremic, aviremic and slow progressor HIV-1-infected subjects. Clin Immunol 2007, 124:149-157.
16. Boulassel M.R., Spurll G., Rouleau D., Tremblay C., Edwardes M., Sekaly R.P., et al. Changes in immunological and virological parameters in HIV-1 infected subjects following leukapheresis. J Clin Apheresis 2003, 18:55-60.
17. Burgard M., Boufassa F., Viard J.P., Garrigue I., Ruffault A., Izopet J., et al. Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients. AIDS 2009, 23:2165-2171.
18. Choi J.Y., Song Y.G., Kim Y.H., Kim C.O., Kim M.S., Chin B.S., et al. Factors associated with HIV-1 proviral DNA loads in patients with undetectable plasma RNA load. J Korean Med Sci 2009, 24:152-154.
19. Koelsch K.K., Liu L., Haubrich R., May S., Havlir D., Günthard H.F., et al. Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis 2008, 197:411-419.
20. Kostrikis L.G., Touloumi G., Karanicolas R., Pantazis N., Anastassopoulou C., Karafoulidou A., et al. Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load. J Virol 2002, 76:10099-100108.
21. Goujard C., Bonarek M., Meyer L., Bonnet F., Chaix M.L., Deveau C., et al. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. Clin Infect Dis 2006, 42:709-715.
22. Rouzioux C., Hubert J.B., Burgard M., Deveau C., Goujard C., Bary M., et al. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. J Infect Dis 2005, 192:46-55.
23. Nasi M., Pinti M., Manzini S., Gibellini L., Manzini L., Bisi L., et al. Predictive value of intracellular HIV-1 DNA levels during CD4-guided treatment interruption in HIV+ patients. AIDS Res Hum Retroviruses 2010, 26:553-558.
24. Pasternak A.O., Jurriaans S., Bakker M., Berkhout B., Lukashov V.V. Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremia. AIDS 2010, 24:1641-1649.
25. Chun T.W., Justement J.S., Pandya P., Hallahan C.W., McLaughlin M., Liu S., et al. Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy. J Infect Dis 2002, 185:1672-1676.
26. Sakai K., Gatanaga H., Takata H., Oka S., Takiguchi M. Comparison of CD4(+) T-cell subset distribution in chronically infected HIV(+) patients with various CD4 nadir counts. Microbes Infect 2010, 12:374-381.
27. Negredo E., Massanella M., Puig J., Pérez-Alvarez N., Gallego-Escuredo J.M., Villarroya J., et al. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications. Clin Infect Dis 2010, 50:1300-1308.
28. Valcour V., Yee P., Williams A.E., Shiramizu B., Watters M., Selnes O., et al. Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection - the Hawaii aging with HIV cohort. J Neurovirol 2006, 12:387-391.